why choose us

First received: October 14, 2024

Clinical Trial: A Study of MK-2225 in Healthy Participants (MK-2225-003)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Systemic Sclerosis

Study Type: INTERVENTIONAL


Official Title: A Multiple Ascending Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-2225 in Healthy Participants

Brief Summary: The purpose of the study is to learn about the safety of MK-2225, including how well people tolerate it.Researchers also want to learn what happens to different doses of MK-2225 in a person's body over time.

Read more